Abiopharma

🔍 MARTIN WILLIAM E. III (Executive)

Company: Azenta, Inc. (AZTA)

Report Date: 2026-04-28

Detailed Transactions and Holdings:

• Acquired 17,790 shares of Common at $24.24 per share (Direct)
  Date: 2026-04-28 | Code: A | equity_swap_involved: false | shares_owned_after: 17,790.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units. The units will vest over three years, 33% on Apriil 18, 2027, 33% on Apriil 18, 2028, and 33% on Apriil 18, 2029.